A programme of phase 3 trials with retatrutide (TRIUMPH) is ongoing with an aim to assess the safety and efficacy of retatrutide in different populations living with obesity (OSA, T2D, established cardiovascular disease, osteoarthritis)
Wegovy, for instance, is specifically approved for chronic weight management, whereas Ozempic is primarily prescribed for the treatment of type 2 diabetes, with weight loss as a beneficial side effect
You might also be able to schedule a B12 injection, which is just as effective as taking B12 orally
No medications are prescribed without a medical evaluation, and patient information is never sold or shared outside of care coordination
It is designed for self-use at home, resembling a pen, making it portable and easy to carry for on-the-go use
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])